Company profile
Silence Therapeutics
Silence Therapeutics is a biotechnology company that develops RNA-based medicines using small interfering RNA (siRNA) technology.
- Location
- London, England, United Kingdom
- Website
- silence-therapeutics.com
Funding
No round listed
This company does not appear in the current investment-round dataset.
Acquisition
Acquired by Merck
- Deal value
- $1.1B
- Announced
- Oct 19, 2026